Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

Gitte Vrelits Sørensen; Patricia A Ganz; Steven W Cole; Lars A Pedersen; Henrik Toft Sørensen; Deirdre Cronin-Fenton; Jens Peter Garne; Peer Michael Christiansen; Timothy Lash; Thomas P Ahern

doi:10.1200/JCO.2012.43.9190

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

Gitte Vrelits Sørensen, Patricia A Ganz, Steven W Cole, Lars A Pedersen, Henrik Toft Sørensen, Deirdre Cronin-Fenton, Jens Peter Garne, Peer Michael Christiansen, Timothy Lash, Thomas P Ahern

Research output: Contribution to journal › Journal article › Research › peer-review

93 Citations (Scopus)

Abstract

To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort.

Original language	English
Journal	Journal of Clinical Oncology
Volume	31
Issue number	18
Pages (from-to)	2265-72
Number of pages	8
ISSN	0732-183X
DOIs	https://doi.org/10.1200/JCO.2012.43.9190
Publication status	Published - 6 May 2013

Keywords

Adrenergic beta-Antagonists
Adult
Aged
Aged, 80 and over
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Breast Neoplasms
Denmark
Female
Humans
Middle Aged
Neoplasm Recurrence, Local
Proportional Hazards Models
Prospective Studies
Registries
Risk Assessment
Risk Factors

Access to Document

10.1200/JCO.2012.43.9190

AUB Link

Search for the material in Aalborg University Library's search engine

Cite this

Sørensen, G. V., Ganz, P. A., Cole, S. W., Pedersen, L. A., Sørensen, H. T., Cronin-Fenton, D., Garne, J. P., Christiansen, P. M., Lash, T., & Ahern, T. P. (2013). Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study. Journal of Clinical Oncology, 31(18), 2265-72. https://doi.org/10.1200/JCO.2012.43.9190

@article{1bd0f8c832494aae8d641cbb791fb33c,

title = "Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study",

abstract = "To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort.",

keywords = "Adrenergic beta-Antagonists, Adult, Aged, Aged, 80 and over, Angiotensin Receptor Antagonists, Angiotensin-Converting Enzyme Inhibitors, Breast Neoplasms, Denmark, Female, Humans, Middle Aged, Neoplasm Recurrence, Local, Proportional Hazards Models, Prospective Studies, Registries, Risk Assessment, Risk Factors",

author = "S{\o}rensen, {Gitte Vrelits} and Ganz, {Patricia A} and Cole, {Steven W} and Pedersen, {Lars A} and S{\o}rensen, {Henrik Toft} and Deirdre Cronin-Fenton and Garne, {Jens Peter} and Christiansen, {Peer Michael} and Timothy Lash and Ahern, {Thomas P}",

year = "2013",

month = may,

day = "6",

doi = "10.1200/JCO.2012.43.9190",

language = "English",

volume = "31",

pages = "2265--72",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "18",

}

Sørensen, GV, Ganz, PA, Cole, SW, Pedersen, LA, Sørensen, HT, Cronin-Fenton, D, Garne, JP, Christiansen, PM, Lash, T & Ahern, TP 2013, 'Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study', Journal of Clinical Oncology, vol. 31, no. 18, pp. 2265-72. https://doi.org/10.1200/JCO.2012.43.9190

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study. / Sørensen, Gitte Vrelits; Ganz, Patricia A; Cole, Steven W et al.
In: Journal of Clinical Oncology, Vol. 31, No. 18, 06.05.2013, p. 2265-72.

Research output: Contribution to journal › Journal article › Research › peer-review

TY - JOUR

T1 - Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence

T2 - A Danish Nationwide Prospective Cohort Study

AU - Sørensen, Gitte Vrelits

AU - Ganz, Patricia A

AU - Cole, Steven W

AU - Pedersen, Lars A

AU - Sørensen, Henrik Toft

AU - Cronin-Fenton, Deirdre

AU - Garne, Jens Peter

AU - Christiansen, Peer Michael

AU - Lash, Timothy

AU - Ahern, Thomas P

PY - 2013/5/6

Y1 - 2013/5/6

N2 - To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort.

AB - To estimate associations between use of β-blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs) and breast cancer recurrence in a large Danish cohort.

KW - Adrenergic beta-Antagonists

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Angiotensin Receptor Antagonists

KW - Angiotensin-Converting Enzyme Inhibitors

KW - Breast Neoplasms

KW - Denmark

KW - Female

KW - Humans

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Proportional Hazards Models

KW - Prospective Studies

KW - Registries

KW - Risk Assessment

KW - Risk Factors

U2 - 10.1200/JCO.2012.43.9190

DO - 10.1200/JCO.2012.43.9190

M3 - Journal article

C2 - 23650417

SN - 0732-183X

VL - 31

SP - 2265

EP - 2272

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 18

ER -

Use of β-Blockers, Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Risk of Breast Cancer Recurrence: A Danish Nationwide Prospective Cohort Study

Abstract

Keywords

Access to Document

AUB Link

Fingerprint

Cite this